Lindera, Rd. – WU YAO
Dosis: 15g/Tag
Das Wirkprofil von Lindera ähnelt demjenigen vieler wie man in der westlichen Phytotherapie sagen würde „blutreinigender“ Kräuter. Traditionell chinesisch ist die „entschleimende“ Wirkung gemeint.
Diese Mittel stimulieren die Zellen dazu, vermehrt toxische Stoffwechselendprodukte abzubauen und helfen so, durch diese hervorgerufene Schäden zu heilen.
So wirkt Lindera gut beim Metabolischen Syndrom, bei Krebs und neurodegenerativen Krankheiten, Allergien, Arthritis und allgemein zur Verlangsamung des Alterungsprozesses, da dieser durch fortschreitende Ablagerung von Oxydationsstoffen bedingt und bescheunigt wird.
- Metabolisches Syndrom
1.1. Diabetes
Thus, the present findings indicate that LOE has a beneficial effect on the vascular system in db/db mice by improving endothelium-dependent relaxations and vascular oxidative stress most likely by normalizing the angiotensin system, and also on metabolic parameters, and these effects are associated with an enhanced physical exercise capacity.
– Water extract of the root of Lindera strychnifolia slows down the progression of diabetic nephropathy in db/db mice
Kidneys of the LR extract-treated group showed glomeruli with greater area and cell population, smaller glomerular sclerotic index, and less fibrosis in glomeruli, where apoptotic rate of glomerular cells were decreased compared with the control kidneys. Furthermore, renal TGF-beta(1) expression was decreased in the LR extract-treated group. These findings suggest that the LR therapy can be a novel therapeutic approach against diabetic nephropathy.
1.2. Hypertonie
The angiotensin-converting enzyme (ACE) activity was reduced in the LOE group compared to that in the control db/db group. LOE also inhibited the activity of purified ACE, COX-1 and COX-2 in a dose-dependent manner. In addition, LOE improved physical exercise capacity
Intake of LOE prevented the angiotensin II-induced increase in systolic blood pressure, and endothelial dysfunction to acetylcholine and oxidative stress as assessed using dihydroethidine in aortic rings. The present findings indicate that LOE has vasoprotective and antihypertensive properties most likely by stimulating the endothelial formation of NO and inhibiting oxidative stress.
Plasma noradrenaline levels were significantly decreased in Lindera-treated SHR group compared to the SHR group. These results suggest that Lindera strychnifolia has an anti-hypertensive effect and improves cardiac function in spontaneous hypertensive rats. These effects may be related to the decrease in plasma noradrenaline levels by Lindera strychnifolia.
1.3. Adipositas
These results provide evidence that dietary intake of lucidone alleviates high fat diet-induced obesity in C57BL/6 mice and reveals the potential of lucidone as a nutraceutical to prevent obesity and consequent metabolic disorders.
Besides interfering with adipogenesis, (+)-episesamin showed anti-inflammatory activity by counteracting the lipopolysaccharide- and tumor necrosis factor α-induced secretion of interleukin 6 by 3T3-L1 preadipocytes. In conclusion, (+)-episesamin seems to be the active drug in the L. obtusiloba extract being responsible for the inhibition of adipogenesis and, thus, should be evaluated as a novel potential complementary treatment for obesity.
- Allergien
The effect of compounds 1-7 on tumor necrosis factor (TNF)-α, interleukin(IL)-6, and their inhibitory activity of histamine release were examined using human mast cells. Among the lignans tested, compounds 1, 3, 4, 6, and 7 inhibited release of histamine from mast cells.
– Phenolic glycosides from Lindera obtusiloba and their anti-allergic inflammatory activities
Our results support the notion that phenolic glycosides isolated from L. obtusiloba inhibit mast-cell-derived allergic inflammation, histamine, and proinflammatory cytokines.
- Hepatitis C
Lucidone suppresses hepatitis C virus replication by Nrf2-mediated heme oxygenase-1 induction
These findings suggest that lucidone could be a potential lead or supplement for the development of new anti-HCV agent in the future
- Krebs
5.1. Leukämie
Cells treated with KEO or linalool for 48 h showed significantly suppressed cell proliferation, with induced apoptosis. Moreover, KEO and linalool promoted cell differentiation. Treatment with KEO cells at the same dose as linalool showed an almost identical effect on HL-60 cells. These results suggest that KEO and linalool have efficacy as anticancer therapeutic products.
5.2. Bronchialkrebs
These findings suggested that the components of L. strychifolia have anticancer activity and may contribute to clinical applications in the prevention and treatment of lung cancer.
5.3. Leberkrebs
Our findings show that anti-neoplastic effects of (+)-episesamin are mediated via suppressed activation of NF-κB which entails a decreased release of pro-inflammatory IL-6. In addition, (+)-episesamin inhibits MMP-9, which is strongly expressed in invasive HCC, and the production of proangiogenic VEGF. We conclude that (+)-episesamin has the potential to be further explored as a complementary treatment for HCC.
- Arthritis
6.1. Rheumatische Arthritis
It was concluded that preventing IL-6 release from FLS might be an important mechanism for NOR displaying anti-RA property, and the action of NOR was relative to inhibition of PKC/MAPKs/p65/CREB pathways
These data suggest that TARL is a potential therapeutic agent for rheumatoid arthritis that suppresses inflammation and protects joints from destruction
- Neurodermitis
Our results showed that topical application of LOWE exerts beneficial effects in AD symptoms, suggesting that LOWE might be a candidate for the treatment of AD.
- Antioxcidation
In conclusion, the Uyaku leaf hot-water extract has potent scavenging activity against reactive oxygen species and reactive nitrogen species, and effectively inhibited lipid peroxidation. These results might contribute to understanding age-associated or free radical-related diseases induced by excess reactive oxygen and also nitrogen species.
- Neurodegenerative Krankheiten
– Neuroprotective effect of methyl lucidone against microglia-mediated neurotoxicity.
The cell viabilities of HT-22 neurons were significantly attenuated by treatment of the conditioned media containing neurotoxic secretary molecules from LPS-stimulated microglia. However, methyl lucidone significantly blocked neuronal cell death induced by microglial conditioned media. These neuroprotective effects of methyl lucidone were also confirmed in a neuron-microglia co-culture system using EGFP-transfected B35 neuroblastoma cell line. Taken together, these results suggest that methyl lucidone may have a neuroprotective potential via inhibition of neurotoxic microglial activation implicated in neurodegeneration.
Lindenenyl acetate, isolated by bioassay-guided fractionation of the MeOH extract of the roots of Lindera strychnifolia, showed potent neuroprotective effects on glutamate-induced neurotoxicity by inducing the expression of HO-1 and increasing the activity of HO in mouse hippocampal HT22 cells.
TCM
Ein Vergleich des Wirkspektrums von Lindera, wie er sich durch die Analyse wissenschaftlicher Studien ergibt, und Benskys TCM-Pharmakopoe ergibt grosse Unterschiede:
Lindera erscheint laut TCM-Quellen als Mittel bei Verdauungsbeschwerden.
Die Wirkung auf innere Krankheiten wie dem Metabolischen Syndrom, Krebs oder Allergien bleibt aussen vor.
Die 5-Elementeanalyse bildet die Energiedynamik von Lindera wie folgt ab:
Blau bedeutet : TCM-Quellen
Grün bedeutet: TCM-Quellen und Studien
Schwarz : Studien
Rot: Studien Hauptwirkung
Zum Verständnis der Abkürzungen des Schaubildes siehe
Struktur – und Wandlungsmodell der chinesischen Medizin
http://www.chinesischemedizin.com/CMS/index.php/struktur-und-wandlungsmodell.html
Diskussionen
Es gibt noch keine Kommentare.